Development of a Novel Assay to Assess the Avidity of Dengue Virus-Specific Antibodies Elicited in Response to a Tetravalent Dengue Vaccine

por Tsuji, Isamu, Dominguez, David, Egan, Michael A, Dean, Hansi J
Publicado 2021

Recombinant vesicular stomatitis virus as an HIV-1 vaccine vector

por Clarke, David K., Cooper, David, Egan, Michael A., Hendry, R. Michael, Parks, Christopher L., Udem, Stephen A.
Publicado 2006

Single dose attenuated Vesiculovax vaccines protect primates against Ebola Makona virus

por Mire, Chad E., Matassov, Demetrius, Geisbert, Joan B., Latham, Theresa E., Agans, Krystle N., Xu, Rong, Ota-Setlik, Ayuko, Egan, Michael A., Fenton, Karla A., Clarke, David K., Eldridge, John H., Geisbert, Thomas W.
Publicado 2015

A highly attenuated Vesiculovax vaccine rapidly protects nonhuman primates against lethal Marburg virus challenge

por Woolsey, Courtney, Cross, Robert W., Agans, Krystle N., Borisevich, Viktoriya, Deer, Daniel J., Geisbert, Joan B., Gerardi, Cheryl, Latham, Theresa E., Fenton, Karla A., Egan, Michael A., Eldridge, John H., Geisbert, Thomas W., Matassov, Demetrius
Publicado 2022

Vaccination With a Highly Attenuated Recombinant Vesicular Stomatitis Virus Vector Protects Against Challenge With a Lethal Dose of Ebola Virus

por Matassov, Demetrius, Marzi, Andrea, Latham, Terri, Xu, Rong, Ota-Setlik, Ayuko, Feldmann, Friederike, Geisbert, Joan B., Mire, Chad E., Hamm, Stefan, Nowak, Becky, Egan, Michael A., Geisbert, Thomas W., Eldridge, John H., Feldmann, Heinz, Clarke, David K.
Publicado 2015

First-in-Human Evaluation of the Safety and Immunogenicity of a Recombinant Vesicular Stomatitis Virus Human Immunodeficiency Virus-1 gag Vaccine (HVTN 090)

por Fuchs, Jonathan D., Frank, Ian, Elizaga, Marnie L., Allen, Mary, Frahm, Nicole, Kochar, Nidhi, Li, Sue, Edupuganti, Srilatha, Kalams, Spyros A., Tomaras, Georgia D., Sheets, Rebecca, Pensiero, Michael, Tremblay, Marc A., Higgins, Terry J., Latham, Theresa, Egan, Michael A., Clarke, David K., Eldridge, John H.
Publicado 2015

A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of Electroporated HIV DNA with or without Interleukin 12 in Prime-Boost Combinations w...

por Mpendo, Juliet, Mutua, Gaudensia, Nyombayire, Julien, Ingabire, Rosine, Nanvubya, Annet, Anzala, Omu, Karita, Etienne, Hayes, Peter, Kopycinski, Jakub, Dally, Len, Hannaman, Drew, Egan, Michael A., Eldridge, John H., Syvertsen, Kristen, Lehrman, Jennifer, Rasmussen, Beth, Gilmour, Jill, Cox, Josephine H., Fast, Patricia E., Schmidt, Claudia
Publicado 2015

Safety and tolerability of HIV-1 multiantigen pDNA vaccine given with IL-12 plasmid DNA via electroporation, boosted with a recombinant vesicular stomatitis virus HIV Gag vaccine i...

por Elizaga, Marnie L., Li, Shuying S., Kochar, Nidhi K., Wilson, Gregory J., Allen, Mary A., Tieu, Hong Van N., Frank, Ian, Sobieszczyk, Magdalena E., Cohen, Kristen W., Sanchez, Brittany, Latham, Theresa E., Clarke, David K., Egan, Michael A., Eldridge, John H., Hannaman, Drew, Xu, Rong, Ota-Setlik, Ayuko, McElrath, M. Juliana, Hay, Christine Mhorag
Publicado 2018

An introduction to the Marburg virus vaccine consortium, MARVAC

por Cross, Robert W., Longini, Ira M., Becker, Stephan, Bok, Karin, Boucher, David, Carroll, Miles W., Díaz, Janet V., Dowling, William E., Draghia-Akli, Ruxandra, Duworko, James T., Dye, John M., Egan, Michael A., Fast, Patricia, Finan, Amy, Finch, Courtney, Fleming, Thomas R., Fusco, Joan, Geisbert, Thomas W., Griffiths, Anthony, Günther, Stephan, Hensley, Lisa E., Honko, Anna, Hunegnaw, Ruth, Jakubik, Jocelyn, Ledgerwood, Julie, Luhn, Kerstin, Matassov, Demetrius, Meshulam, Jeffrey, Nelson, Emily V., Parks, Christopher L., Rustomjee, Roxana, Safronetz, David, Schwartz, Lauren M., Smith, Dean, Smock, Paul, Sow, Ydrissa, Spiropoulou, Christina F., Sullivan, Nancy J., Warfield, Kelly L., Wolfe, Daniel, Woolsey, Courtney, Zahn, Roland, Henao-Restrepo, Ana María, Muñoz-Fontela, César, Marzi, Andrea
Publicado 2022